Literature DB >> 17665971

Therapeutic and clinical applications of nitroxide compounds.

Benjamin P Soule1, Fuminori Hyodo, Ken-Ichiro Matsumoto, Nicole L Simone, John A Cook, Murali C Krishna, James B Mitchell.   

Abstract

Nitroxide compounds have been used for many years as biophysical tools, but only during the past 15-20 years have the many interesting biochemical interactions been discovered and harnessed for therapeutic applications. By modifying oxidative stress and altering the redox status of tissues, nitroxides have the ability to interact with and alter many metabolic processes. This interaction can be exploited for therapeutic and research use, including protection against ionizing radiation, as probes in functional magnetic resonance imaging, cancer prevention and treatment, control of hypertension and weight, and protection from damage resulting from ischemia/reperfusion injury. Although much remains to be done, many applications have been well studied, and some are presently being tested in clinical trials. The therapeutic and research uses of nitroxides are reviewed here, with a focus on the progress from initial development to modern, state-of-the art trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665971     DOI: 10.1089/ars.2007.1722

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  26 in total

1.  Attenuation of dichlorvos-induced microglial activation and neuronal apoptosis by 4-hydroxy TEMPO.

Authors:  Aditya Sunkaria; Deep Raj Sharma; Willayat Yousuf Wani; Kiran Dip Gill
Journal:  Mol Neurobiol       Date:  2013-07-25       Impact factor: 5.590

2.  Redox properties of the nitronyl nitroxide antioxidants studied via their reactions with nitroxyl and ferrocyanide.

Authors:  A A Bobko; V V Khramtsov
Journal:  Free Radic Res       Date:  2015-03-19

3.  The evaluation of new and isotopically labeled isoindoline nitroxides and an azaphenalene nitroxide for EPR oximetry.

Authors:  Nadeem Khan; James P Blinco; Steven E Bottle; Kazuyuki Hosokawa; Harold M Swartz; Aaron S Micallef
Journal:  J Magn Reson       Date:  2011-05-23       Impact factor: 2.229

Review 4.  Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics.

Authors:  Frederick A Villamena; Amlan Das; Kevin M Nash
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

5.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

6.  Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy.

Authors:  Zhentai Huang; Jianfei Jiang; Natalia A Belikova; Detcho A Stoyanovsky; Valerian E Kagan; Arlan H Mintz
Journal:  J Neurooncol       Date:  2010-09-12       Impact factor: 4.130

Review 7.  Targeted delivery of radioprotective agents to mitochondria.

Authors:  Irina Zabbarova; Anthony Kanai
Journal:  Mol Interv       Date:  2008-12

8.  4-Hydroxy TEMPO attenuates dichlorvos induced microglial activation and apoptosis.

Authors:  Aditya Sunkaria; Deep Raj Sharma; Willayat Yousuf Wani; Kiran Dip Gill
Journal:  ACS Chem Neurosci       Date:  2014-01-06       Impact factor: 4.418

Review 9.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

10.  Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides.

Authors:  Martin D Rees; Steven E Bottle; Kathryn E Fairfull-Smith; Ernst Malle; John M Whitelock; Michael J Davies
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.